Article Information
History
- May 4, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dvora Leah Joseph Davey1,2,3,*,
- Rufaro Mvududu2,
- Nyiko Mashele2,
- Maia Lesosky2,
- Nehaa Khadka1,
- Jessica More2,
- Linda-Gail Bekker3,
- Pamina Gorbach1,
- Thomas J. Coates4,
- Landon Myer2 and
- on behalf of PrEP-PP study team
- 1Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, California, United States of America
- 2Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
- 3The Desmond Tutu Health Foundation, University of Cape Town, Cape Town, South Africa
- 4David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America
- ↵* Corresponding author; email: dvoradavey{at}ucla.edu
Posted May 04, 2021.
Early pre-exposure prophylaxis (PrEP) discontinuation among pregnant and postpartum women: Implications for maternal PrEP roll out in South Africa
